## Pathophysiology of Secondary Hyperparathyroidism in CKD ### The Correct Concept **Key Point:** FGF23 (fibroblast growth factor 23) is an early phosphaturic hormone that INCREASES in CKD to maintain phosphate balance. However, FGF23 does NOT suppress PTH — rather, elevated FGF23 itself is a marker of dysregulation and occurs alongside rising PTH. The statement that FGF23 "suppresses PTH secretion" is fundamentally incorrect. ### Sequence of Events in CKD-MBD | Stage | Key Event | Mechanism | |-------|-----------|----------| | Early CKD (GFR 45–60) | FGF23 ↑↑ | Phosphate retention → FGF23 rises to promote urinary P loss | | Early CKD (GFR 45–60) | PTH ↑ | Phosphate retention + ↓ calcitriol → PTH stimulation | | Late CKD (GFR <30) | PTH ↑↑↑ | Severe hyperphosphatemia + hypocalcemia + ↓ calcitriol | **High-Yield:** FGF23 and PTH rise *together* in CKD, not in opposition. FGF23 does not suppress PTH; both are elevated due to phosphate retention. ### Why the Other Statements Are Correct 1. **Hyperphosphatemia directly stimulates PTH:** True. Phosphate is a direct stimulus for PTH secretion, independent of calcium. This is a key mechanism in early CKD. 2. **Decreased calcitriol → secondary hyperparathyroidism:** True. Reduced renal 1α-hydroxylase activity in CKD decreases calcitriol production, reducing intestinal calcium absorption and stimulating PTH. 3. **Phosphate retention in stage 3 CKD:** True. Declining GFR causes phosphate retention, which is the primary initial trigger for PTH elevation before hypocalcemia develops. **Clinical Pearl:** The classic sequence is: ↓ GFR → phosphate retention → ↑ FGF23 and ↑ PTH (in parallel) → ↓ calcitriol → ↓ serum calcium → further ↑ PTH. FGF23 and PTH are both consequences of phosphate retention, not antagonists. [cite:Harrison 21e Ch 279]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.